Yang Jingchao, Xu Jinzhu, Xu Shuanglan, Fan Zeqin, Zhu Chenshao, Wan Jianyuan, Yang Jiao, Xing Xiqian
Department of Pulmonary and Critical Care Medicine, First Affiliated Hospital of Kunming Medical University, 650032, Kunming, China.
Department of Pulmonary and Critical Care Medicine, Yuxi Municipal Hospital of T.C. M, 653100, Yuxi, China.
Thromb J. 2024 Jan 12;22(1):9. doi: 10.1186/s12959-023-00577-1.
Oxidative stress is an imbalance between the body's reactive oxygen species and antioxidant defense mechanisms. Oxidative stress is involved in the development of several cardiovascular diseases, such as pulmonary hypertension, atherosclerosis, and diabetes mellitus. A growing number of studies have suggested the potential role of oxidative stress in the pathogenesis of pulmonary embolism. Biomarkers of oxidative stress in pulmonary embolism have also been explored, such as matrix metalloproteinases, asymmetric dimethylarginine, and neutrophil/lymphocyte ratio. Here, we comprehensively summarize some oxidative stress mechanisms and biomarkers in the development of acute pulmonary embolism and summarize related treatments based on antioxidant stress to explore effective treatment strategies for acute pulmonary embolism.
氧化应激是机体活性氧与抗氧化防御机制之间的失衡。氧化应激参与多种心血管疾病的发生发展,如肺动脉高压、动脉粥样硬化和糖尿病。越来越多的研究表明氧化应激在肺栓塞发病机制中具有潜在作用。人们也对肺栓塞中氧化应激的生物标志物进行了探索,如基质金属蛋白酶、不对称二甲基精氨酸和中性粒细胞/淋巴细胞比值。在此,我们全面总结急性肺栓塞发生发展过程中的一些氧化应激机制和生物标志物,并总结基于抗氧化应激的相关治疗方法,以探索急性肺栓塞的有效治疗策略。